$1.8 MM EBITDA PHARMA COMPANY SEEKING SALE OF CONTROL STAKE

Looking for a buyer.
Transaction Overview

Spektrum Capital is seeking sale of control stake

▪ Fully Integrated Specialty Pharma firm with end to end Prescription Generics drug development, Manufacturing and Commercialization

▪ 2020 Revenue $8.7M, with an adj EBIDA of $1.82M (1)

▪ Strong marketing partners network with ANDA portfolio of 70+ drugs, with 29 approved as of April[redacted]).

▪ 25000 sq.ft manufacturing facility with an additional[redacted]sq.ft available for expansion(1)

▪ #50+ employees

▪ Experienced team of founders, with a proven track record of scaling up Outsourced services business.

▪ With new ANDA approvals, the firm expects revenue, profits and cashflow to improve significantly (1).

listing type
exclusive representation
industry
[redacted]
location
[redacted]
revenue
[redacted]
ebitda
[redacted]

It appears you don't have a PDF plugin for this browser.

Click here to download the PDF file.



share: